Vimal D. Mehta

Director, Chief Executive Officer, President & Secretary at BioXcel Therapeutics, Inc.

Vimal D. Mehta

Vimal D. Mehta

Director, Chief Executive Officer, President & Secretary at BioXcel Therapeutics, Inc.

Overview
Career Highlights

BioXcel Therapeutics, Inc.
BioXcel LLC
BioXcel Corp.

RelSci Relationships

105

Number of Boards

2

Birthday

1961

Age

60
Relationships
View Relationship Details
RelSci Relationships are individuals Vimal D. Mehta likely has professional access to. A relationship does not necessarily indicate a personal connection.
Krishnan Nandabalan

Co-Founder at BioXcel Corp.

Relationship likelihood: Strong

Sandeep Laumas

Managing Member at Bearing Circle Advisors LLC

Relationship likelihood: Strong

Eric Rowinsky

Executive Chairman at Rgenix, Inc.

Relationship likelihood: Strong

Peter Mueller

Director-BioTech Council at US India Chamber of Commerce

Relationship likelihood: Strong

Richard I. Steinhart

Chief Financial Officer & Vice President at BioXcel Therapeutics, Inc.

Relationship likelihood: Strong

Frank Yocca

Chief Scientific Officer, Bioxcel Therapeutics, Inc at BioXcel Corp.

Relationship likelihood: Strong

William P. Kane

Executive Vice President & Chief Commercial Officer at BioXcel Therapeutics, Inc.

Relationship likelihood: Strong

Reina Benabou

Chief Development Officer & Senior Vice President at BioXcel Therapeutics, Inc.

Relationship likelihood: Strong

Vincent O'Neill

Chief Medical Officer at BioXcel Therapeutics, Inc.

Relationship likelihood: Strong

Johann De Bono

European Principal Investigator at BioXcel Therapeutics, Inc.

Relationship likelihood: Strong

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.
In The News
GlobeNewswire
January 5, 2021
BioXcel Therapeutics Announces BXCL501 Met the Primary and All Secondary Endpoints in the TRANQUILITY Phase 1b/2 Study for the Acute Treatment of Agitation in Dementia, including Alzheimer’s Disease
ENP Newswire
November 16, 2020
-BioXcel Therapeutics to Participate in the Jefferies Virtual London Healthcare Conference
ENP Newswire
August 17, 2020
-BioXcel Therapeutics Reports Second Quarter 2020 Financial Results and Provides Business Update
ENP Newswire
August 7, 2020
-BioXcel Therapeutics to Participate in the Canaccord Genuity 40th Annual Growth Conference
ENP Newswire
July 8, 2020
-BioXcel Therapeutics Announces Notice of Allowance for U.S. Patent Application Covering Formulation for BXCL501 and Methods of Treating Agitation
Trending People
Rohit Chopra
Hoffa: Chopra Will Be An Active Watchdog Overseeing Nation's Financial Sector - PR Newswire
Tedros Adhanom Ghebreyesus
Covid Response Was a Global Series of Failures, W.H.O. Panel Says - The New York Times
Kamala D. Harris
Warnock honors King on eve of holiday - St. Louis Post-Dispatch (Missouri)
Barack Obama
Trouble at home may change Biden’s hand in Iran nuke talks - The Miami Herald
Gary S. Gensler
Biden picks Chopra, Gensler for financial oversight roles - The Independent UK
Trending People
Rohit Chopra
Hoffa: Chopra Will Be An Active Watchdog Overseeing Nation's Financial Sector - PR Newswire
Tedros Adhanom Ghebreyesus
Covid Response Was a Global Series of Failures, W.H.O. Panel Says - The New York Times
Kamala D. Harris
Warnock honors King on eve of holiday - St. Louis Post-Dispatch (Missouri)
Barack Obama
Trouble at home may change Biden’s hand in Iran nuke talks - The Miami Herald
Gary S. Gensler
Biden picks Chopra, Gensler for financial oversight roles - The Independent UK
Paths to Vimal D. Mehta
Potential Connections via
Relationship Science
You
Vimal D. Mehta
Director, Chief Executive Officer, President & Secretary at BioXcel Therapeutics, Inc.
Education
University of Delhi

University of Delhi is a premier Indian educational institution, with a status so high that president of India serves as the Visitor.

Career History
Director, Chief Executive Officer, President & Secretary
2017 - Current
BioXcel Therapeutics, Inc.

BioXcel Therapeutics, Inc. is a clinical stage biopharmaceutical company, which focuses on drug development. The firm's two clinical development programs are BXCL501, a sublingual thin film formulation designed for acute treatment of agitation resulting from neurological and psychiatric disorders, and BXCL701, an immuno-oncology agent designed for treatment of a rare form of prostate cancer and for treatment of pancreatic cancer. The company was founded by Vimal D. Mehta on March 29, 2017 and is headquartered in New Haven, CT.

Co-Founder
2005 - Current
BioXcel Corp.

BioXcel Corp. is an American private company located in Branford, CT. The firm provides pharma data analytics solutions. It was founded by Krishnan Nandabalan and Vimal D. Mehta. Vimal D. Mehta is the current CEO, occupying that position since 2005. BioXcel Corp. owns a significant share in BioXcel Therapeutics, Inc. (41.08 %).The company says this about itself: BioXcel is a biopharmaceutical company pioneering the integration of big data analytics and machine learning-based artificial intelligence with drug development expertise to advance the next wave of medicines, impacting the probability of success of drugs. Our focus is to develop innovative medicines that address immuno-oncology, neuroscience and rare diseases with high unmet medical need. Committed to innovation, product excellence and partner success, BioXcel's global collaborations span the biopharmaceutical ecosystem. We are headquartered in Branford, CT, USA with operations in Asia.

Chief Executive Officer
Current
BioXcel LLC

Transactions
Details Hidden

BioXcel Therapeutics, Inc. issued USD Common Stock

Public Holdings
Restricted data only for RelSci Professional users.
Other Affiliations

Vimal D. Mehta is affiliated with BioXcel Therapeutics, Inc., BioXcel Corp., BioXcel LLC, Jubilant Life Sciences (USA), Inc., Galapagos Biotech Ltd., CuraGen Corporation, The University of Texas - Southwestern Medical Center

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Vimal D. Mehta. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Vimal D. Mehta's profile does not indicate a business or promotional relationship of any kind between RelSci and Vimal D. Mehta.